Nurix Therapeutics, Inc. (NRIX) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0001549595 · SEC filings checked Oct 18, 2026

    Next report
    Jan 18, 2027
    Estimated from reporting history (96-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
    Last close
    $24.42
    Polygon.io daily close, Oct 16, 2026. End of day, not live.
    Trailing diluted EPS
    $2.30
    Sum of quarters ending Aug 31, 2026, May 31, 2026, Feb 28, 2026, Nov 30, 2025 · P/E 10.6

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Aug 31, 2026Oct 13, 2026$673.1M$549.8M$4.73Filing
    May 31, 2026Jul 9, 2026$9.0M$-89.5M$-0.81Filing
    Feb 28, 2026Apr 8, 2026$6.3M$-87.2M$-0.79Filing
    Nov 30, 2025Jan 28, 2026$13.6M$-78.2M$-0.83Filing
    Aug 31, 2025Oct 9, 2025$7.9M$-86.4M$-1.03Filing
    May 31, 2025Jul 9, 2025$44.1M$-43.5M$-0.52Filing
    Feb 28, 2025Apr 8, 2025$18.5M$-56.4M$-0.67Filing
    Nov 30, 2024Jan 13, 2025$13.3M$-58.5M$-0.74Filing

    What would Nurix Therapeutics, Inc. have to report for its valuation to change?

    At $24.42, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -1.9% a year, to $2.09. On that path the next quarter needs diluted EPS near $-0.81, against $-0.83 in the quarter ended Nov 30, 2025.

    Are you considering buying, or do you already own shares?

    Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.

    ResultOriginalYours
    Required EPS growth / year-1.9%-1.9%
    EPS needed in final year$2.09$2.09

    Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.

    Prepare for earnings across my investments — $399/month

    Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. NRIX goes in with your buy-or-wait comparison and assumptions preserved.

    Start Desk — $399/month

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.